Palumbo Wealth Management LLC purchased a new stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 12,851 shares of the exchange traded fund’s stock, valued at approximately $766,000.
Separately, Laurel Wealth Advisors LLC increased its stake in ProShares Ultra Nasdaq Biotechnology by 4,481.0% in the second quarter. Laurel Wealth Advisors LLC now owns 13,743 shares of the exchange traded fund’s stock valued at $630,000 after purchasing an additional 13,443 shares during the period.
ProShares Ultra Nasdaq Biotechnology Stock Performance
Shares of NASDAQ:BIB opened at $87.37 on Tuesday. The company has a 50-day simple moving average of $83.29 and a 200-day simple moving average of $72.08. ProShares Ultra Nasdaq Biotechnology has a one year low of $33.78 and a one year high of $89.06. The stock has a market capitalization of $91.74 million, a price-to-earnings ratio of 20.68 and a beta of 1.38.
ProShares Ultra Nasdaq Biotechnology Cuts Dividend
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.
Recommended Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Elon Musk already made me a “wealthy man”
- SELL Alert: Oracle Corporation (ORCL)
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Elon Musk: This Could Turn $100 into $100,000
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
